TIZANIDINE

Clinical Indication

Generalised spasticity for patients who have been stabilised on a dose

Comments

To revert to secondary care only, when there are any dose changes and doses of 12mg a day or more require secondary care prescribing for 4 months whilst monthly LFTs are undertaken by secondary care.

Date of classification

May 2015

Review date

February 2021

Amber SIMPLE

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.